Expediting telehealth use in clinical research studies: recommendations for overcoming barriers in North America.

Expediting telehealth use in clinical research studies: recommendations for overcoming barriers in North America.
复制标题

DOI:
10.1038/s41531-021-00177-8
复制
发表时间:
2021-04-12
期刊:
NPJ Parkinson's disease
影响因子:
--
通讯作者:
Beck JC
Beck JC
中科院分区:
其他
文献类型:
--
作者:
Naito A;Wills AM;Tropea TF;Ramirez-Zamora A;Hauser RA;Martino D;Turner TH;Rafferty MR;Afshari M;Williams KL;Vaou O;McKeown MJ;Ginsburg L;Ezra A;Iansek R;Wallock K;Evers C;Schroeder K;DeLeon R;Yarab N;Alcalay RN;Beck JC

文献摘要

参考文献

被引文献

相似文献

尽管有数据支持远程医疗在北美提供临床护理中的快速采用,但在临床研究中实施远程医疗就诊仍面临严重障碍。这些挑战包括:(1) 远程医疗各州许可要求的变化; (2) 弱势群体在获得远程医疗方面存在差异; (3) 各个研究审查委员会 (IRB) 之间缺乏一致性。每个障碍都阻碍了研究方案的系统转换以包括远程医疗就诊。帕金森病基金会和帕金森研究小组成员提交此评论,以强调当前在临床研究中实施远程医疗就诊所面临的挑战。我们的目标是提供一份共识声明,强调监管机构迫切需要标准化远程医疗实践的采用,并提出建议以减轻现有研究协议的实施负担。
Despite data supporting the rapid adoption of telehealth in the delivery of clinical care in North America, the implementation of telehealth visits in clinical research studies has faced critical barriers. These challenges include: (1) variations in state licensure requirements for telehealth; (2) disparities in access to telehealth among disadvantaged populations; (3) lack of consistency among individual Investigational Review Boards (IRBs). Each barrier prevents the systematic conversion of research protocols to include telehealth visits. The Parkinson’s Foundation and members of the Parkinson Study Group submit this Comment to highlight current challenges to implementing telehealth visits for clinical research studies. Our objective is to provide a consensus statement emphasizing the urgent need for regulators to standardize adoption of telehealth practices and to propose recommendations to reduce the burden for implementation in existing research study protocols.
DOI: 10.1038/s41531-020-00153-8
发表时间: 2021-01-21
期刊: NPJ Parkinson's disease
影响因子: --
作者:
Feeney MP;Xu Y;Surface M;Shah H;Vanegas-Arroyave N;Chan AK;Delaney E;Przedborski S;Beck JC;Alcalay RN
通讯作者: Alcalay RN
DOI: 10.3233/jpd-202163
发表时间: 2020-01-01
影响因子: 5.2
作者:
Tarolli, Christopher G.;Andrzejewski, Kelly;Simuni, Tanya
通讯作者: Simuni, Tanya
DOI: 10.1002/mds.28284
发表时间: 2020-10-01
期刊: MOVEMENT DISORDERS
影响因子: 8.6
作者:
Hassan, Anhar;Mari, Zoltan;Cubo, Esther
通讯作者: Cubo, Esther
DOI: 10.1377/hlthaff.19.4.76
发表时间: 2000-07-01
期刊: HEALTH AFFAIRS
影响因子: 9.7
作者:
Saha, S;Taggart, SH;Bindman, AB
通讯作者: Bindman, AB
DOI: 10.1001/jamaneurol.2013.123
发表时间: 2013-05
期刊: JAMA NEUROLOGY
影响因子: 29
作者:
Dorsey, E. Ray;Venkataraman, Vinayak;Grana, Matthew J.;Bull, Michael T.;George, Benjamin P.;Boyd, Cynthia M.;Beck, Christopher A.;Rajan, Balaraman;Seidmann, Abraham;Biglan, Kevin M.
通讯作者: Biglan, Kevin M.